AI assistant
Sending…
CONMED Corp — Director's Dealing 2011
Mar 4, 2011
31971_dirs_2011-03-04_8f1adf0d-d6bc-45f2-a4ed-179d3826be2e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2011-03-02
Reporting Person: CORASANTI EUGENE R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-02 | Common Stock | S | 5268 | $26.07 | Disposed | 88182 | Direct |
| 2011-03-03 | Common Stock | S | 24732 | $26.43 | Disposed | 63450 | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.25 to $26.65, inclusive. The reporting person undertakes to provide to CONMED Corporation, any security holder of CONMED Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each seperate price within the ranges.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7